The effect of thoracic duct lymph drainage in myasthenia gravis.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D004322:Drainage; D005069:Evaluation Studies as Topic; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007136:Immunoglobulins; D007165:Immunosuppression Therapy; D008196:Lymph / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000276:immunology* / Q000628:therapy; D013897:Thoracic Duct; D013934:Thymectomy
D002800:Cholinesterase Inhibitors; D007136:Immunoglobulins; D000324:Adrenocorticotropic Hormone; D001379:Azathioprine